Lucy R. Wedderburn focuses on Immunology, Internal medicine, Juvenile dermatomyositis, Dermatomyositis and Arthritis. Lucy R. Wedderburn usually deals with Internal medicine and limits it to topics linked to Endocrinology and RANKL, Osteoprotegerin and Osteoclast. Her research integrates issues of Autoantibody, Physical therapy, Systematic review and Myositis in her study of Juvenile dermatomyositis.
Her research in Dermatomyositis intersects with topics in Gastroenterology, Polymyositis, Autoimmune disease and Major histocompatibility complex. Her studies deal with areas such as Genome-wide association study and Disease as well as Arthritis. Her work carried out in the field of FOXP3 brings together such families of science as T cell and IL-2 receptor.
Lucy R. Wedderburn mainly investigates Internal medicine, Immunology, Arthritis, Juvenile dermatomyositis and Rheumatology. Lucy R. Wedderburn combines subjects such as Gastroenterology and Physical therapy with her study of Internal medicine. As a part of the same scientific study, Lucy R. Wedderburn usually deals with the Immunology, concentrating on Single-nucleotide polymorphism and frequently concerns with Haplotype.
Her Arthritis research incorporates elements of Juvenile, Prospective cohort study, Methotrexate and Disease. Her Juvenile dermatomyositis study integrates concerns from other disciplines, such as Myositis and Intensive care medicine. Her Rheumatology study combines topics from a wide range of disciplines, such as Disease activity, Pediatrics and Bioinformatics.
Arthritis, Juvenile dermatomyositis, Internal medicine, Disease and Immunology are her primary areas of study. Lucy R. Wedderburn has researched Arthritis in several fields, including Biomarker, Juvenile, Prospective cohort study and Single-nucleotide polymorphism. Her Juvenile dermatomyositis research is multidisciplinary, relying on both Disease activity, Gerontology, Pathogenesis, Muscle weakness and Intensive care medicine.
Lucy R. Wedderburn focuses mostly in the field of Internal medicine, narrowing it down to topics relating to Gastroenterology and, in certain cases, Interquartile range. Her Disease research is multidisciplinary, incorporating elements of Developmental psychology, Clinical trial, Meta-analysis and Psychosocial. Her work in Immunology addresses issues such as Synovial fluid, which are connected to fields such as Innate lymphoid cell and Peripheral blood mononuclear cell.
Her primary scientific interests are in Immunology, Arthritis, Juvenile dermatomyositis, Disease and Internal medicine. Lucy R. Wedderburn interconnects Single-nucleotide polymorphism and Anakinra in the investigation of issues within Immunology. Lucy R. Wedderburn works mostly in the field of Arthritis, limiting it down to topics relating to Prospective cohort study and, in certain cases, Cross-sectional study.
In her research, Cytokine, Interferon and Hormone is intimately related to Toll-like receptor, which falls under the overarching field of Juvenile dermatomyositis. Her Disease research integrates issues from Meta-analysis, Immune system and Intensive care. Lucy R. Wedderburn focuses mostly in the field of Internal medicine, narrowing it down to topics relating to Physical therapy and, in certain cases, Epidemiology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans
Kevin W. Ng;Nikhil Faulkner;Georgina H. Cornish;Annachiara Rosa.
CD4+CD25bright Regulatory T Cells Actively Regulate Inflammation in the Joints of Patients with the Remitting Form of Juvenile Idiopathic Arthritis
Ismé M. de Kleer;Lucy R. Wedderburn;Leonie S. Taams;Alka Patel.
Journal of Immunology (2004)
Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment.
Kiran Nistala;Stuart Adams;Helen Cambrook;Simona Ursu.
Proceedings of the National Academy of Sciences of the United States of America (2010)
Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers.
Kiran Nistala;Halima Moncrieffe;Katy R Newton;Hemlata Varsani.
Arthritis & Rheumatism (2008)
Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis
Anne Hinks;Anne Hinks;Joanna E. Cobb;Joanna E. Cobb;Miranda C. Marion;Sampath Prahalad.
Nature Genetics (2013)
Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission.
Hannah Peckham;Nina M. de Gruijter;Charles Raine;Anna Radziszewska.
Nature Communications (2020)
Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study
Wilco de Jager;Esther P A H Hoppenreijs;Nico M Wulffraat;Lucy R Wedderburn.
Annals of the Rheumatic Diseases (2007)
T-cell control of Epstein-Barr virus-infected B cells is lost during P. falciparum malaria.
Hilton C. Whittle;Jim Brown;Kevin Marsh;Brian M. Greenwood.
The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)—clinical characteristics of children recruited within the first 5 yr
L J McCann;A D Juggins;S M Maillard;L R Wedderburn.
Methotrexate Withdrawal at 6 vs 12 Months in Juvenile Idiopathic Arthritis in Remission: A Randomized Clinical Trial
Dirk Foell;Nico Wulffraat;Lucy R. Wedderburn;Helmut Wittkowski.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: